Recommendations for prevention and control of influenza in children, 2015-2016

Carrie L. Byington, Yvonne A. Maldonado, Elizabeth D. Barnett, Herbert Dele Davies, Kathryn M. Edwards, Ruth Lynfield, Flor M. Munoz, Dawn L. Nolt, Ann Christine Nyquist, Mobeen H. Rathore, Mark H. Sawyer, William J. Steinbach, Tina Q. Tan, Theoklis E. Zaoutis

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The purpose of this statement is to update recommendations for routine use of seasonal influenza vaccine and antiviral medications for the prevention and treatment of influenza in children. The American Academy of Pediatrics recommends annual seasonal influenza immunization for all people 6 months and older, including all children and adolescents. Highlights for the upcoming 2015-2016 season include the following: 1. Annual universal influenza immunization is indicated with either a trivalent or quadrivalent vaccine (no preference). 2. The 2015-2016 influenza A (H3N2) and B (Yamagata lineage) vaccine strains differ from those contained in the 2014-2015 seasonal vaccines. a. Trivalent vaccine contains an A/California/7/2009 (H1N1) pdm09-like virus; an A/Switzerland/9715293/2013 (H3N2)-like virus; and a B/Phuket/ 3073/2013-like virus (B/Yamagata lineage). b. Quadrivalent vaccine contains an additional B virus (B/Brisbane/60/2008- like virus [B/Victoria lineage]). 3. The dosing algorithm for administration of influenza vaccine to children 6 months through 8 years of age has been updated to reflect that virus strains in the vaccine have changed from last season. With an increasing number of organizations mandating influenza vaccine, all health care personnel should receive influenza vaccine each season and fully promote influenza vaccine use and infection-control measures. In addition, pediatricians should promptly identify children clinically presumed to have influenza disease for rapid antiviral treatment, when indicated, to reduce morbidity and mortality.

Original languageEnglish (US)
Pages (from-to)792-808
Number of pages17
JournalPediatrics
Volume136
Issue number4
DOIs
StatePublished - Oct 1 2015

Fingerprint

Influenza Vaccines
Human Influenza
Vaccines
Cercopithecine Herpesvirus 1
Antiviral Agents
Immunization
H3N2 Subtype Influenza A Virus
Viruses
Victoria
Infection Control
Switzerland
Health Personnel
Organizations
Pediatrics
Morbidity
Delivery of Health Care
Mortality
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Byington, C. L., Maldonado, Y. A., Barnett, E. D., Davies, H. D., Edwards, K. M., Lynfield, R., ... Zaoutis, T. E. (2015). Recommendations for prevention and control of influenza in children, 2015-2016. Pediatrics, 136(4), 792-808. https://doi.org/10.1542/peds.2015-2920

Recommendations for prevention and control of influenza in children, 2015-2016. / Byington, Carrie L.; Maldonado, Yvonne A.; Barnett, Elizabeth D.; Davies, Herbert Dele; Edwards, Kathryn M.; Lynfield, Ruth; Munoz, Flor M.; Nolt, Dawn L.; Nyquist, Ann Christine; Rathore, Mobeen H.; Sawyer, Mark H.; Steinbach, William J.; Tan, Tina Q.; Zaoutis, Theoklis E.

In: Pediatrics, Vol. 136, No. 4, 01.10.2015, p. 792-808.

Research output: Contribution to journalArticle

Byington, CL, Maldonado, YA, Barnett, ED, Davies, HD, Edwards, KM, Lynfield, R, Munoz, FM, Nolt, DL, Nyquist, AC, Rathore, MH, Sawyer, MH, Steinbach, WJ, Tan, TQ & Zaoutis, TE 2015, 'Recommendations for prevention and control of influenza in children, 2015-2016', Pediatrics, vol. 136, no. 4, pp. 792-808. https://doi.org/10.1542/peds.2015-2920
Byington CL, Maldonado YA, Barnett ED, Davies HD, Edwards KM, Lynfield R et al. Recommendations for prevention and control of influenza in children, 2015-2016. Pediatrics. 2015 Oct 1;136(4):792-808. https://doi.org/10.1542/peds.2015-2920
Byington, Carrie L. ; Maldonado, Yvonne A. ; Barnett, Elizabeth D. ; Davies, Herbert Dele ; Edwards, Kathryn M. ; Lynfield, Ruth ; Munoz, Flor M. ; Nolt, Dawn L. ; Nyquist, Ann Christine ; Rathore, Mobeen H. ; Sawyer, Mark H. ; Steinbach, William J. ; Tan, Tina Q. ; Zaoutis, Theoklis E. / Recommendations for prevention and control of influenza in children, 2015-2016. In: Pediatrics. 2015 ; Vol. 136, No. 4. pp. 792-808.
@article{d9ba6e9dce984024b9ed56cf05d68af2,
title = "Recommendations for prevention and control of influenza in children, 2015-2016",
abstract = "The purpose of this statement is to update recommendations for routine use of seasonal influenza vaccine and antiviral medications for the prevention and treatment of influenza in children. The American Academy of Pediatrics recommends annual seasonal influenza immunization for all people 6 months and older, including all children and adolescents. Highlights for the upcoming 2015-2016 season include the following: 1. Annual universal influenza immunization is indicated with either a trivalent or quadrivalent vaccine (no preference). 2. The 2015-2016 influenza A (H3N2) and B (Yamagata lineage) vaccine strains differ from those contained in the 2014-2015 seasonal vaccines. a. Trivalent vaccine contains an A/California/7/2009 (H1N1) pdm09-like virus; an A/Switzerland/9715293/2013 (H3N2)-like virus; and a B/Phuket/ 3073/2013-like virus (B/Yamagata lineage). b. Quadrivalent vaccine contains an additional B virus (B/Brisbane/60/2008- like virus [B/Victoria lineage]). 3. The dosing algorithm for administration of influenza vaccine to children 6 months through 8 years of age has been updated to reflect that virus strains in the vaccine have changed from last season. With an increasing number of organizations mandating influenza vaccine, all health care personnel should receive influenza vaccine each season and fully promote influenza vaccine use and infection-control measures. In addition, pediatricians should promptly identify children clinically presumed to have influenza disease for rapid antiviral treatment, when indicated, to reduce morbidity and mortality.",
author = "Byington, {Carrie L.} and Maldonado, {Yvonne A.} and Barnett, {Elizabeth D.} and Davies, {Herbert Dele} and Edwards, {Kathryn M.} and Ruth Lynfield and Munoz, {Flor M.} and Nolt, {Dawn L.} and Nyquist, {Ann Christine} and Rathore, {Mobeen H.} and Sawyer, {Mark H.} and Steinbach, {William J.} and Tan, {Tina Q.} and Zaoutis, {Theoklis E.}",
year = "2015",
month = "10",
day = "1",
doi = "10.1542/peds.2015-2920",
language = "English (US)",
volume = "136",
pages = "792--808",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "4",

}

TY - JOUR

T1 - Recommendations for prevention and control of influenza in children, 2015-2016

AU - Byington, Carrie L.

AU - Maldonado, Yvonne A.

AU - Barnett, Elizabeth D.

AU - Davies, Herbert Dele

AU - Edwards, Kathryn M.

AU - Lynfield, Ruth

AU - Munoz, Flor M.

AU - Nolt, Dawn L.

AU - Nyquist, Ann Christine

AU - Rathore, Mobeen H.

AU - Sawyer, Mark H.

AU - Steinbach, William J.

AU - Tan, Tina Q.

AU - Zaoutis, Theoklis E.

PY - 2015/10/1

Y1 - 2015/10/1

N2 - The purpose of this statement is to update recommendations for routine use of seasonal influenza vaccine and antiviral medications for the prevention and treatment of influenza in children. The American Academy of Pediatrics recommends annual seasonal influenza immunization for all people 6 months and older, including all children and adolescents. Highlights for the upcoming 2015-2016 season include the following: 1. Annual universal influenza immunization is indicated with either a trivalent or quadrivalent vaccine (no preference). 2. The 2015-2016 influenza A (H3N2) and B (Yamagata lineage) vaccine strains differ from those contained in the 2014-2015 seasonal vaccines. a. Trivalent vaccine contains an A/California/7/2009 (H1N1) pdm09-like virus; an A/Switzerland/9715293/2013 (H3N2)-like virus; and a B/Phuket/ 3073/2013-like virus (B/Yamagata lineage). b. Quadrivalent vaccine contains an additional B virus (B/Brisbane/60/2008- like virus [B/Victoria lineage]). 3. The dosing algorithm for administration of influenza vaccine to children 6 months through 8 years of age has been updated to reflect that virus strains in the vaccine have changed from last season. With an increasing number of organizations mandating influenza vaccine, all health care personnel should receive influenza vaccine each season and fully promote influenza vaccine use and infection-control measures. In addition, pediatricians should promptly identify children clinically presumed to have influenza disease for rapid antiviral treatment, when indicated, to reduce morbidity and mortality.

AB - The purpose of this statement is to update recommendations for routine use of seasonal influenza vaccine and antiviral medications for the prevention and treatment of influenza in children. The American Academy of Pediatrics recommends annual seasonal influenza immunization for all people 6 months and older, including all children and adolescents. Highlights for the upcoming 2015-2016 season include the following: 1. Annual universal influenza immunization is indicated with either a trivalent or quadrivalent vaccine (no preference). 2. The 2015-2016 influenza A (H3N2) and B (Yamagata lineage) vaccine strains differ from those contained in the 2014-2015 seasonal vaccines. a. Trivalent vaccine contains an A/California/7/2009 (H1N1) pdm09-like virus; an A/Switzerland/9715293/2013 (H3N2)-like virus; and a B/Phuket/ 3073/2013-like virus (B/Yamagata lineage). b. Quadrivalent vaccine contains an additional B virus (B/Brisbane/60/2008- like virus [B/Victoria lineage]). 3. The dosing algorithm for administration of influenza vaccine to children 6 months through 8 years of age has been updated to reflect that virus strains in the vaccine have changed from last season. With an increasing number of organizations mandating influenza vaccine, all health care personnel should receive influenza vaccine each season and fully promote influenza vaccine use and infection-control measures. In addition, pediatricians should promptly identify children clinically presumed to have influenza disease for rapid antiviral treatment, when indicated, to reduce morbidity and mortality.

UR - http://www.scopus.com/inward/record.url?scp=84942875583&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942875583&partnerID=8YFLogxK

U2 - 10.1542/peds.2015-2920

DO - 10.1542/peds.2015-2920

M3 - Article

C2 - 26347430

AN - SCOPUS:84942875583

VL - 136

SP - 792

EP - 808

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 4

ER -